Abstract:Abstract Background Microglia activation induced by α-synuclein (α-syn) is one of the most important factors in Parkinson’s disease (PD) pathogenesis. However, the molecular mechanisms by which α-syn exerts neuroinflammation and neurotoxicity remain largely elusive. Targeting metabotropic glutamate receptor 5 (mGluR5) has been an attractive strategy to mediate microglia activation for neuroprotection, which might be an essential regulator to modulate α-syn-induced neuroinflammation for the treatment of PD. Here, we showed that mGluR5 inhibited α-syn-induced microglia inflammation to protect from neurotoxicity in vitro and in vivo. Methods Co-immunoprecipitation assays were utilized to detect the interaction between mGluR5 and α-syn in microglia. Griess, ELISA, real-time PCR, western blotting, and immunofluorescence assays were used to detect the regulation of α-syn-induced inflammatory signaling, cytokine secretion, and lysosome-dependent degradation. Results α-syn selectively interacted with mGluR5 but not mGluR3, and α-syn N terminal deletion region was essential for binding to mGluR5 in co-transfected HEK293T cells. The interaction between these two proteins was further detected in BV2 microglia, which was inhibited by the mGluR5 specific agonist CHPG without effect by its selective antagonist MTEP. Moreover, in both BV2 cells and primary microglia, activation of mGluR5 by CHPG partially inhibited α-syn-induced inflammatory signaling and cytokine secretion and also inhibited the microglia activation to protect from neurotoxicity. We further found that α-syn overexpression decreased mGluR5 expression via a lysosomal pathway, as evidenced by the lysosomal inhibitor, NH 4 Cl, by blocking mGluR5 degradation, which was not evident with the proteasome inhibitor, MG132. Additionally, co-localization of mGluR5 with α-syn was detected in lysosomes as merging with its marker, LAMP-1. Consistently, in vivo experiments with LPS- or AAV-α-syn-induced rat PD model also confirmed that α-syn accelerated lysosome-dependent degradation of mGluR5 involving a complex, to regulate neuroinflammation. Importantly, the binding is strengthened with LPS or α-syn overexpression but alleviated by urate, a potential clinical biomarker for PD. Conclusions These findings provided evidence for a novel mechanism by which the association of α-syn with mGluR5 was attributed to α-syn-induced microglia activation via modulation of mGluR5 degradation and its intracellular signaling. This may be a new molecular target for an effective therapeutic strategy for PD pathology.

HMGB1 Promotes the Starvation-Induced Autophagic Degradation of Α-Synuclein in SH-SY5Y Cells Atg 5-Dependently

HMGB1 Mediates Autophagy Dysfunction Via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell Model

alpha-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson's disease

α‐synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson’s disease

Overexpressed Alpha-Synuclein Regulated the Nuclear Factor-kappaB Signal Pathway

Autophagy-dependent Removal of Α-Synuclein: a Novel Mechanism of GM1 Ganglioside Neuroprotection Against Parkinson's Disease.

Α-Synuclein Accumulation in SH-SY5Y Cell Impairs Autophagy in Microglia by Exosomes Overloading Mir-19A-3p.

HMGB1-induced Autophagy Facilitates Hepatic Stellate Cells Activation: a New Pathway in Liver Fibrosis

Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson’s disease

Hdac6 Regulates Aggresome-Autophagy Degradation Pathway Of Alpha-Synuclein In Response To Mpp Plus -Induced Stress

Nutrient Deprivation Induces Α-Synuclein Aggregation Through Endoplasmic Reticulum Stress Response and SREBP2 Pathway.

HDAC6 regulates aggresome-autophagy degradation pathway of α-synuclein in response to MPP+-induced stress.

Regulation of α-synuclein homeostasis and inflammasome activation by microglial autophagy

HDAC6-mediated Hsp90 deacetylation reduces aggregation and toxicity of the protein alpha-synuclein by regulating chaperone-mediated autophagy

Mitophagy Upregulation Occurs Early in the Neurodegenerative Process Mediated by α-Synuclein

Elevated α-synuclein levels inhibit mitophagic flux

Expression of Mutant but Not Wild-Type Α-Synuclein in SH-SY5Y Cells Induces Apoptosis and Autophagy: Implication for Regulation of Cell Death in Parkinson's Disease

GAPDH siRNA Regulates SH-SY5Y Cell Apoptosis Induced by Exogenous α-Synuclein Protein

Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson’s disease

Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice

The progression of HMGB1-induced autophagy in cancer biology